Fusion Health Care launches COVID-19 drug Favipiravir and an immunity booster
Shortpedia
Content Team
Image Credit: shortpedia
Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases. It gives us immense satisfaction to launch `XARAVIR` as this drug has the potential to save precious lives. We have launched the product at an affordable price, said Madhu Ramadugu, Managing Director.
